Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents, Renal Artery Stents, Carotid Artery Stents and Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

October 2016 | 87 pages | ID: VD4F7A4D724EN
Zion Market Research

Abstracts

The report covers forecast and analysis for the vascular stents market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the vascular stents market on a global level.

In order to give the users of this report a comprehensive view on the vascular stents market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the vascular stents market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the vascular stents market by segmenting the market based on product and region. The different product includes fem-pop artery stents, iliac artery stents, renal artery stents, carotid artery stents and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of vascular stents market are Cordis Corporation, Boston Scientific Corporation, C. R. Bard, Inc, Cook Medical and W.L. Gore Associates and Abbott Vascular, Inc.

This report segments the vascular stents market as follows:

Vascular Stents Market: Product Segment Analysis

Fem-pop artery stents
Iliac artery stents
Renal artery stents
Carotid artery stents
Others

Vascular Stents Market: Regional Segment Analysis

North America
Europe
Asia Pacific
Latin America
Middle East Africa

Contents

CHAPTER 1. PREFACE

1.1. Report Description
1.2. Research Scope
1.3. Research Methodology
  1.3.1. Market Research Process
  1.3.2. Market Research Methodology

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Global Vascular Stents Market , 2015 - 2021 (USD Million)
2.2. Global Vascular Stents Market: Snapshot

CHAPTER 3. VASCULAR STENTS INDUSTRY ANALYSIS

3.1. Introduction
3.2. Classification of Vascular Stents Market
3.3. Market Drivers
  3.3.1. Growth in Global Population and Aging Demographics
  3.3.2. Minimally Invasive Procedure
3.4. Restraints
  3.4.1. High Cost of Vascular Stents
3.5. Opportunities
  3.5.1. Technological Advancement
3.6. Porters Five Forces Analysis
3.7. Vascular Stents: Market Attractiveness Analysis
3.8. Market Attractiveness Analysis by Product
3.9. Market Attractiveness Analysis by Regional Segment

CHAPTER 4. COMPETITIVE LANDSCAPE

4.1. Company Market Share Analysis
  4.1.1. Global Vascular Stents Market: Company Market Share, 2015
4.2. Strategic Development
  4.2.1. Acquisitions Mergers
  4.2.2. New Product Launch
  4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.3. Patent Analysis (2011-2016)
  4.3.1. Number of Patent (2011 2016)
  4.3.2. Patent Share by Company

CHAPTER 5. VASCULAR STENTS MARKET PRODUCT SEGMENT ANALYSIS

5.1. Global Vascular Stents Market Overview: By Product
  5.1.1. Global Vascular Stents Market, by Product, 2015 2021
5.2. Fem-Pop Artery Stents
  5.2.1. Global Fem-Pop Artery Stents Market, 2015 2021 (USD Million)
5.3. Iliac Artery Stents
  5.3.1. Global Iliac Artery Stents Market, 2015 2021 (USD Million)
5.4. Renal Artery Stents
  5.4.1. Global Renal Artery Stents Market, 2015 2021 (USD Million)
5.5. Carotid Artery Stents
  5.5.1. Global Carotid Artery Stents Market, 2015 2021 (USD Million)
5.6. Other Products
  5.6.1. Global Vascular Stents Market for Other Products, 2015 2021 (USD Million)

CHAPTER 6. VASCULAR STENTS MARKET REGIONAL ANALYSIS

6.1. Global Vascular Stents Market: Regional Overview
  6.1.1. Global Vascular Stents Market Revenue Share, by Region, 2015 2021
6.2. North America
  6.2.1. North America Vascular Stents Market, 2015 - 2021 (USD Million)
  6.2.2. North America Vascular Stents Market, by Product, 2015 2021 (USD Million)
6.3. Europe
  6.3.1. Europe Vascular Stents Market , 2015 - 2021 (USD Million)
  6.3.2. Europe Vascular Stents Market Revenue, by Product, 2015 2021 (USD Million)
6.4. Asia Pacific
  6.4.1. Asia Pacific Vascular Stents Market , 2015 - 2021 (USD Million)
  6.4.2. Asia Pacific Vascular Stents Market, by Product, 2015 2021 (USD Million)
6.5. Latin America
  6.5.1. Latin America Vascular Stents Market , 2015 - 2021 (USD Million)
  6.5.2. Latin America Vascular Stents Market Revenue, by Product, 2015 2021 (USD Million)

CHAPTER 7. MIDDLE EAST AND AFRICA

7.1. Middle East and Africa Vascular Stents Market , 2015 - 2021 (USD Million)
7.2. Middle East and Africa Vascular Stents Market Revenue, by Product, 2015 2021 (USD Million)

CHAPTER 8. COMPANY PROFILES

8.1. Cordis Corporation
  8.1.1. Company Overview
  8.1.2. Financials
  8.1.3. Product Portfolio
  8.1.4. Business Strategy
  8.1.5. Recent Developments
8.2. Boston Scientific Corporation.
  8.2.1. Company Overview
  8.2.2. Financials
  8.2.3. Product Portfolio
  8.2.4. Business Strategy
  8.2.5. Recent Developments
8.3. Abbott Vascular, Inc
  8.3.1. Company Overview
  8.3.2. Financials
  8.3.3. Product Portfolio
  8.3.4. Business Strategy
  8.3.5. Recent Developments
8.4. W. L. Gore Associates, Inc.
  8.4.1. Company Overview
  8.4.2. Product Portfolio
  8.4.3. Business Strategy
  8.4.4. Recent Developments
8.5. C. R. Bard, Inc.
  8.5.1. Company Overview
  8.5.2. Product Portfolio
  8.5.3. Business Strategy
  8.5.4. Recent Developments
8.6. Cook Medical
  8.6.1. Company Overview
  8.6.2. Product Portfolio
  8.6.3. Product Portfolio
  8.6.4. Business Strategy
  8.6.5. Recent Developments

CHAPTER 9. PATENTS

9.1. U.S. (U.S. Patent)
9.2. Europe (EP Documents)
9.3. Japan (Abstract of Japan)
9.4. Global (WIPO (PCT))